Amagasaki, Japan

Fumio Samizo


Average Co-Inventor Count = 4.2

ph-index = 2

Forward Citations = 7(Granted Patents)


Location History:

  • Moriguchi, JP (1993)
  • Amagasaki, JP (2004)

Company Filing History:


Years Active: 1993-2004

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Fumio Samizo: Innovator in Pharmaceutical Chemistry

Introduction

Fumio Samizo is a notable inventor based in Amagasaki, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative patents. With a total of 2 patents, Samizo has demonstrated his expertise and commitment to advancing medical science.

Latest Patents

Samizo's latest patents include groundbreaking work on hydroxamic acid derivatives. This patent describes a hydroxamic acid derivative represented by a specific formula, which acts as a matrix metalloproteinase inhibitor. Another significant patent focuses on a sustained-release preparation of a basic medical agent hydrochloride. This preparation is designed to release the active agent at a controlled rate, ensuring that it is not influenced by the physiological factors of the gastrointestinal tract when administered orally.

Career Highlights

Fumio Samizo is currently associated with Sumitomo Pharmaceuticals Company Limited, where he continues to contribute to pharmaceutical innovations. His work has been instrumental in developing new therapeutic agents that can improve patient outcomes.

Collaborations

Throughout his career, Samizo has collaborated with esteemed colleagues, including Akira Uemura and Tetsuo Noguchi. These collaborations have further enriched his research and development efforts in the pharmaceutical industry.

Conclusion

Fumio Samizo's contributions to pharmaceutical chemistry through his patents highlight his innovative spirit and dedication to improving medical treatments. His work continues to influence the field and pave the way for future advancements.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…